Chronic News and Research

RSS

New electrical pattern in brains predicts how well individual animals fare in stressful situations

Some people can handle stressful situations better than others, and it's not all in their genes: Even identical twins show differences in how they respond.

30 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.

29 Jul 2014

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around 1200 HEV-containing blood components (eg, red cells, platelets, and fresh frozen plasma) are likely to be transfused every year in England.

29 Jul 2014

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

Sufferers of Chronic Fatigue Syndrome are set to benefit with the dual launch of a specialist Griffith University clinic and smartphone app, both aimed to manage their illness and improve health outcomes.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

About 100 drugs already approved by the U.S. Food and Drug Administration (FDA) for other purposes can also prevent the growth of certain bacterial pathogens inside human cells, including those that cause Legionnaires' disease, brucellosis, and Mediterranean spotted fever.

29 Jul 2014

New study evaluates relationship between family policies, gender inequalities in health in Europe

A new study of the European project SOPHIE has evaluated the relationship between the type of family policies and gender inequalities in health in Europe.

29 Jul 2014

Non-endoscopic procedure effective in treating severe chronic migraine headaches

A revised version of a surgical procedure to treat severe chronic migraine headaches led to significant symptom relief more than 90 percent of the time in patients treated at Massachusetts General Hospital.

29 Jul 2014

Opioid use does not impair reverse shoulder arthroplasty success

Taking opioids prior to reverse shoulder arthroplasty does not hamper patients’ chances of having successful outcomes, researchers have found.

28 Jul 2014

Pneumococcal pneumonia mortality falling

Between 2000 and 2013 there has been an increase in the early prescription of antibiotics and use of combination therapy in patients with pneumococcal pneumonia, researchers report.

28 Jul 2014

Researchers receive grant to improve treatment for patients with COPD

Research into improving treatment for patients with one of the UK's most common respiratory diseases has received a -810,000 funding boost.

28 Jul 2014

New study in recognition of World Hepatitis Day released on Life Sciences Connect

The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.

28 Jul 2014

Lifestyle impacts likelihood of developing metabolic syndrome in childhood cancer survivors

A St. Jude Children's Research Hospital study found that 73 percent of adult survivors of childhood cancer more than doubled their risk of developing metabolic syndrome and related health problems by failing to follow a heart-healthy lifestyle. The results appear in the current issue of the journal Cancer.

28 Jul 2014

Researchers provide global genotype prevalence estimates for HCV

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.

28 Jul 2014

Despite public programs, food insecurity remains an intractable problem in the US

Vulnerable populations such as children, the elderly, ethnic minorities, and low-income households are disproportionately affected by food security, despite the extensive private and public food safety net in the United States, according to a new report by RTI International.

27 Jul 2014

Scientists find high proportion of oral bacteria in gut microbiota of liver cirrhosis patients

Scientists from INRA in collaboration with a Chinese team found that the gut microbiota[1] of individuals with liver cirrhosis differ notably from healthy individuals', showing a high proportion of oral bacteria.

26 Jul 2014

Melatonin has protective effects on traumatic brain injury-induced cerebral cortex

Traumatic brain injury can cause post-traumatic neurodegenerations with an increase in reactive oxygen species and reactive oxygen species-mediated lipid peroxidation. Melatonin, a non-enzymatic antioxidant and neuroprotective agent, has been shown to counteract oxidative stress-induced pathophysiologic conditions like cerebral ischemia/reperfusion injury, neuronal excitotoxicity and chronic inflammation.

26 Jul 2014

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.

26 Jul 2014

SAVE Medicare Home Health Act replaces unprecedented rebasing cuts

Home health leaders today said that growing support for the Securing Access Via Excellence (SAVE) Medicare Home Health Act – introduced last week by Representatives Greg Walden (OR-2) and Tom Price (GA-6) – underscores the importance of legislation to repeal the 14 percent, four-year rebasing cuts instituted by the Centers for Medicare and Medicaid Services (CMS) on January 1.

26 Jul 2014

Chronic News and Research

New electrical pattern in brains predicts how well individual animals fare in stressful situations

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

New study evaluates relationship between family policies, gender inequalities in health in Europe

Non-endoscopic procedure effective in treating severe chronic migraine headaches

Opioid use does not impair reverse shoulder arthroplasty success

Pneumococcal pneumonia mortality falling

Researchers receive grant to improve treatment for patients with COPD

New study in recognition of World Hepatitis Day released on Life Sciences Connect

Lifestyle impacts likelihood of developing metabolic syndrome in childhood cancer survivors

Researchers provide global genotype prevalence estimates for HCV

Despite public programs, food insecurity remains an intractable problem in the US

Scientists find high proportion of oral bacteria in gut microbiota of liver cirrhosis patients

Melatonin has protective effects on traumatic brain injury-induced cerebral cortex

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

SAVE Medicare Home Health Act replaces unprecedented rebasing cuts

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News